ACEOMEZ esomeprazole (as magnesium) 20 mg enteric coated tablet blister pack

Pays: Australie

Langue: anglais

Source: Department of Health (Therapeutic Goods Administration)

Ingrédients actifs:

esomeprazole magnesium, Quantity: 22.264 mg

Disponible depuis:

Jubilant Pharma Australia Pty Ltd

forme pharmaceutique:

Tablet, enteric coated

Composition:

Excipient Ingredients: light magnesium oxide; pregelatinised maize starch; glyceryl monostearate; macrogol 6000; hypromellose phthalate; crospovidone; silicon dioxide; methacrylic acid - ethyl acrylate copolymer (1:1); iron oxide red; macrogol 400; polysorbate 80; microcrystalline cellulose; povidone; lactose monohydrate; purified talc; hyprolose; titanium dioxide; hypromellose; iron oxide yellow; maize starch; sucrose

Mode d'administration:

Oral

Unités en paquet:

56, 15, 7, 30, 100

Type d'ordonnance:

(S4) Prescription Only Medicine

indications thérapeutiques:

ACEOMEZ is indicated for: Gastro-Oesophageal Reflux Disease (GORD). ? treatment of erosive reflux oesophagitis ? long-term management of patients with healed oesophagitis to prevent relapse ? symptomatic treatment of gastro-oesophageal reflux disease (GORD),Patients requiring NSAID therapy. ? short-term treatment of upper gastrointestinal symptoms associated with non-steroidal anti- inflammatory drug NSAID (non-selective and COX-2 selective) therapy. ? healing of gastric ulcers associated with non-steroidal anti-inflammatory drug NSAID (non-selective and COX-2 selective) therapy ? prevention of gastric and duodenal ulcers associated with non-steroidal anti-inflammatory drug NSAID (non-selective and COX-2 selective) therapy in patients at risk.,Prevention of rebleeding of gastric or duodenal ulcers following treatment with esomeprazole IV (available in other brands) solution by intravenous infusion. Pathological hypersecretory conditions including Zollinger-Ellison syndrome and idiopathic hypersecretion.,In combination with appropriate antibiotics for: ? healing of duodenal ulcer associated with Helicobacter pylori ? eradication of Helicobacter pylori in patients with active or healed peptic ulcer

Descriptif du produit:

Visual Identification: Light pink coloured, oblong, biconvex, coated tablets debossed with 20 on one side and CE on the other.; Container Type: Blister Pack; Container Material: Other composite material; Container Life Time: 24 Months; Container Temperature: Store below 25 degrees Celsius; Container Closure: Neither child resistant closure nor restricted flow insert

Statut de autorisation:

Registered

Date de l'autorisation:

2020-05-04